Rafeh Naqash, Abdul, Li V. Yang, Edward J. Sanderlin, Druid C. Atwell, and Paul R. Walker. 2018. “Interleukin-6 As One of the Potential Mediators of Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Blockade: Evidence from a Case Report”. Acta Oncologica 57 (5):705-8. https://doi.org/10.1080/0284186X.2017.1406668.